NYSE:PFEPharmaceuticals
Pfizer (PFE) Margin Expansion Surpasses Expectations, Challenging Bearish Narratives on Profit Outlook
Pfizer (PFE) delivered headline earnings growth over the past twelve months, with net profit margins climbing to 15.6% from 7% a year earlier, and earnings soaring by 133.3%. This sharp turnaround follows a difficult five-year stretch during which average earnings declined by 13.2% per year. However, the company reported a significant one-off loss of $7.0 billion in the trailing twelve months, and forward guidance points to revenue declining at 3.2% annually with expected earnings growth of...